IL159620A0 - Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same - Google Patents

Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same

Info

Publication number: IL159620A0
Authority: IL; Israel
Prior art keywords: photodynamic therapy; photosensitizer; diagnosis; preparing same; galenic formulation
Prior art date: 2001-07-17

Application number

IL15962002A

Other languages

English (en)

Original Assignee

Steba Biotech N V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-17

Filing date

2002-07-05

Publication date

2004-06-01

2002-07-05 Application filed by Steba Biotech N V filed Critical Steba Biotech N V

2004-06-01 Publication of IL159620A0 publication Critical patent/IL159620A0/xx

Links

239000000203 mixture Substances 0.000 title abstract 3
238000002428 photodynamic therapy Methods 0.000 title abstract 3
238000003745 diagnosis Methods 0.000 title 1
238000009472 formulation Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 6
239000003504 photosensitizing agent Substances 0.000 abstract 4
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
230000002776 aggregation Effects 0.000 abstract 2
238000004220 aggregation Methods 0.000 abstract 2
229910052783 alkali metal Inorganic materials 0.000 abstract 2
-1 alkali metal salt Chemical class 0.000 abstract 2
239000008365 aqueous carrier Substances 0.000 abstract 2
239000007972 injectable composition Substances 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
239000004094 surface-active agent Substances 0.000 abstract 2
235000019445 benzyl alcohol Nutrition 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
239000013020 final formulation Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Inorganic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL15962002A 2001-07-17 2002-07-05 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same IL159620A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01810708A EP1277470A1 (de)	2001-07-17	2001-07-17	Injizierbare galenische Zubereitung zur Anwendung in einer photodynamischen Therapie oder Diagnose und Verfahren zu ihrer Herstellung
PCT/IB2002/002661 WO2003009842A1 (fr)	2001-07-17	2002-07-05	Formulation galenique injectable pour utilisation dan un diagnostic ou une therapie photodynamique et son procede de preparation

Publications (1)

Publication Number	Publication Date
IL159620A0 true IL159620A0 (en)	2004-06-01

Family

ID=8184036

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15962002A IL159620A0 (en)	2001-07-17	2002-07-05	Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same

Country Status (20)

Country	Link
US (1)	US20040147500A1 (de)
EP (2)	EP1277470A1 (de)
JP (1)	JP2004537562A (de)
CN (1)	CN1303999C (de)
AT (1)	ATE372769T1 (de)
BR (1)	BR0211173A (de)
CA (1)	CA2454150A1 (de)
DE (1)	DE60222421T2 (de)
DK (1)	DK1406616T3 (de)
ES (1)	ES2292781T3 (de)
HU (1)	HUP0400754A3 (de)
IL (1)	IL159620A0 (de)
MX (1)	MXPA04000042A (de)
NO (1)	NO20040216L (de)
NZ (1)	NZ530634A (de)
PL (1)	PL368503A1 (de)
PT (1)	PT1406616E (de)
RU (1)	RU2278665C2 (de)
WO (1)	WO2003009842A1 (de)
ZA (1)	ZA200400328B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7825153B2 (en) *	2004-08-16	2010-11-02	Ceramoptec Industries, Inc.	Photosensitizer formulations and their use
KR100866728B1 (ko) *	2004-11-12	2008-11-03	주식회사종근당	타크로리무스를 함유하는 주사제
EP2008665A1 (de) *	2007-06-25	2008-12-31	Steba Biotech N.V.	Injizierbare Formulierung für die photodynamische Therapie
RU2565766C1 (ru) *	2014-11-17	2015-10-20	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга"	4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения
ES2895851T3 (es) *	2016-04-01	2022-02-22	Trioptotec Gmbh	Dispersión de fotosensibilizador y uso de la misma
CN108670950B (zh) *	2018-06-29	2020-10-02	深圳海王医药科技研究院有限公司	一种不含有机溶剂的虎杖苷药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2963178B2 (ja) *	1990-09-27	1999-10-12	株式会社エス・エル・ティ・ジャパン	水溶性フェオホーバイドａの製造方法
US5654423A (en) *	1990-11-21	1997-08-05	Regents Of The University Of California	Boronated metalloporphyrine and therapeutic methods
JPH08505054A (ja) *	1992-12-23	1996-06-04	アイオアステートユニバーシティーリサーチファンデーションインコーポレーテッド	分子フラッシュ
US6147195A (en) *	1993-07-26	2000-11-14	Yeda Research And Development Co., Ltd.	Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US5462726A (en) *	1993-12-17	1995-10-31	Bristol-Myers Squibb Company	Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
US5616342A (en) *	1995-04-11	1997-04-01	Pdt, Inc.	Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
IL116126A0 (en) *	1995-11-24	1996-01-31	Yeda Res & Dev	Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
RU2144085C1 (ru) *	1996-07-12	2000-01-10	Московская государственная академия тонкой химической технологии им.М.В.Ломоносова	Способ получения бактериохлорофилла а
EP1137411B1 (de) *	1998-12-09	2006-12-06	YEDA RESEARCH AND DEVELOPMENT Co. LTD.	Palladiumsubstituierte bakteriochlorophyllderivate und deren verwendung

2001
- 2001-07-17 EP EP01810708A patent/EP1277470A1/de not_active Withdrawn
2002
- 2002-07-05 EP EP02747627A patent/EP1406616B1/de not_active Expired - Lifetime
- 2002-07-05 WO PCT/IB2002/002661 patent/WO2003009842A1/fr not_active Ceased
- 2002-07-05 DK DK02747627T patent/DK1406616T3/da active
- 2002-07-05 IL IL15962002A patent/IL159620A0/xx unknown
- 2002-07-05 US US10/484,154 patent/US20040147500A1/en not_active Abandoned
- 2002-07-05 PT PT02747627T patent/PT1406616E/pt unknown
- 2002-07-05 RU RU2004104469/15A patent/RU2278665C2/ru not_active IP Right Cessation
- 2002-07-05 BR BR0211173-0A patent/BR0211173A/pt not_active IP Right Cessation
- 2002-07-05 MX MXPA04000042A patent/MXPA04000042A/es active IP Right Grant
- 2002-07-05 HU HU0400754A patent/HUP0400754A3/hu unknown
- 2002-07-05 CN CNB028142918A patent/CN1303999C/zh not_active Expired - Fee Related
- 2002-07-05 JP JP2003515235A patent/JP2004537562A/ja active Pending
- 2002-07-05 DE DE60222421T patent/DE60222421T2/de not_active Expired - Fee Related
- 2002-07-05 PL PL02368503A patent/PL368503A1/xx unknown
- 2002-07-05 CA CA002454150A patent/CA2454150A1/fr not_active Abandoned
- 2002-07-05 AT AT02747627T patent/ATE372769T1/de not_active IP Right Cessation
- 2002-07-05 NZ NZ530634A patent/NZ530634A/en unknown
- 2002-07-05 ES ES02747627T patent/ES2292781T3/es not_active Expired - Lifetime
2004
- 2004-01-15 ZA ZA200400328A patent/ZA200400328B/en unknown
- 2004-01-16 NO NO20040216A patent/NO20040216L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003009842A8 (fr)	2004-04-01
PL368503A1 (en)	2005-04-04
JP2004537562A (ja)	2004-12-16
EP1277470A1 (de)	2003-01-22
DE60222421T2 (de)	2008-06-05
ZA200400328B (en)	2004-09-13
ES2292781T3 (es)	2008-03-16
EP1406616B1 (de)	2007-09-12
MXPA04000042A (es)	2005-08-16
WO2003009842A1 (fr)	2003-02-06
BR0211173A (pt)	2004-08-10
US20040147500A1 (en)	2004-07-29
CA2454150A1 (fr)	2003-02-06
CN1303999C (zh)	2007-03-14
RU2004104469A (ru)	2005-04-20
ATE372769T1 (de)	2007-09-15
CN1529594A (zh)	2004-09-15
HUP0400754A3 (en)	2005-11-28
RU2278665C2 (ru)	2006-06-27
NO20040216L (no)	2004-03-17
HUP0400754A2 (hu)	2004-07-28
NZ530634A (en)	2006-11-30
DK1406616T3 (da)	2008-01-21
DE60222421D1 (de)	2007-10-25
EP1406616A1 (de)	2004-04-14
PT1406616E (pt)	2007-12-20

Publication	Publication Date	Title
EP1158959A4 (de)	2004-12-08	Zusammensetzungen und verfahren zur verbesserten verabreichung hydrophober therapeutischer wirkstoffe
JP4804431B2 (ja)	2011-11-02	長時間作用オキシテトラサイクリン組成物
CA2117651A1 (en)	1993-09-30	Itraconazole and saperconazole stereoisomers
AU2001293233A1 (en)	2002-03-13	Aza heterocyclic derivatives and their therapeutic use
ATE307808T1 (de)	2005-11-15	Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
ES2056259T3 (es)	1994-10-01	Derivados de carboestirilo.
IL159620A0 (en)	2004-06-01	Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
IL158155A (en)	2009-12-24	Use of erythropoietin for the preparation of a medicament to ameliorate chemotherapy-induced toxicity
DE69223736D1 (de)	1998-02-05	Acridine-1,8-Dionderivate als therapeutisches Mittel
GR3025207T3 (en)	1998-02-27	2-Formylpyridine thiosemicarbazone derivatives, their preparation and their use as antitumor agents
CA2090911A1 (en)	1994-01-08	Aqueous pharmaceutical formulations of sodium cromoglycate
HUT68190A (en)	1995-05-29	Process for producing ergoline derivatives of serotoninergic activity
CA2412594A1 (en)	2002-01-03	Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives
IL141232A0 (en)	2002-03-10	Use of camptothecin derivatives, with reduced gastrointestinal toxicity
WO2004095921A3 (en)	2005-06-30	Sporicidal composition
CA2071837A1 (en)	1992-04-17	Vitamin-Mineral Treatment Methods and Compositions
WO2003026570A3 (en)	2004-01-22	Reduced toxicity cisplatin formulations and methods for using the same
US5814635A (en)	1998-09-29	Concentrated injection solution of alkali metal salts of reduced folates
HUT46214A (en)	1988-10-28	Process for producing medical preparation suitable for treatment of peptic ulcer
CA2244085A1 (en)	1997-07-31	Therapeutic anti-asthma agents containing selenium compounds
AU2415699A (en)	1999-07-26	1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
WO2003013380A3 (en)	2003-08-21	Multi-part dental bleaching systems and method for bleaching teeth using such systems
JP2822049B2 (ja)	1998-11-05	水性製剤組成物
HUP0301334A2 (hu)	2003-08-28	Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók
JPS5527133A (en)	1980-02-27	Drug comprising organosilicon compound as main constituent